Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001612528-26-000002

Director acquired 12,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
COATS LONNEL Director 2026-10-19 Grant or award +12,400 12,400 D
Derivatives
COATS LONNEL Director 2026-10-19 Grant or award · Stock Option +16,600 16,600 D
Loading xslF345X06/wk-form4_1792531965.xml…